ERNST-GUNTER AFTING, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2003-07-14 We are a party to a consulting agreement with Dr. Ernst-Gunter Afting pursuant to which he receives fees of $7,000 annually.

Data sourced from SEC filings. Last updated: 2026-02-03